Skip to main content
Clinical Trials/DRKS00033035
DRKS00033035
Recruiting
Not Applicable

Association of end-stage renal disease with the prognosis and hemostasis of patients with atrial flimmern or coronary heart disease - HERACles

niversitätsklinikum Freiburg0 sites238 target enrollmentApril 4, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
chronic kidney diseaseatrial fibrillationcoronary heart disease
Sponsor
niversitätsklinikum Freiburg
Enrollment
238
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 4, 2024
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients over 18 years old with chronic kidney insufficiency from stage IV according to KDIGO
  • known atrial fibrillation and/or coronary heart disease
  • Stable kidney retention parameters
  • consistent administration of anticoagulants/platelet aggregation inhibitors and no medication change for at least 1 week, or no anticoagulants/platelet aggregation inhibitors due to high bleeding risk.

Exclusion Criteria

  • Patients with known coagulation disorders, liver insufficiency, or active cancer disease
  • Acute kidney failure in the current hospital stay
  • Severe thrombocytopenia (\< 100,000/µl) or thrombocytosis (\> 450,000/µl)
  • Noncompliance, lack of consistent medication intake

Outcomes

Primary Outcomes

Not specified

Similar Trials